Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.17, $0.06 better than the analyst estimate of $0.11. Revenue for the quarter came in at $32.5 million versus the consensus estimate of $31.13 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.